Gender differences in acute coronary syndromes patterns during the COVID-19 outbreak.
COVID-19
Gender
acute coronary syndromes
Journal
American journal of cardiovascular disease
ISSN: 2160-200X
Titre abrégé: Am J Cardiovasc Dis
Pays: United States
ID NLM: 101569582
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
07
2020
accepted:
29
09
2020
entrez:
23
11
2020
pubmed:
24
11
2020
medline:
24
11
2020
Statut:
epublish
Résumé
Mortality from acute coronary syndromes (ACS) is strictly related to early management. As female patients usually experience longer delays before diagnosis and treatment, we assessed whether women were more affected by the dramatic drop in hospital admissions for ACS during the Covid-19 pandemic. We performed a retrospective analysis of clinical and angiographic characteristics of consecutive patients who were admitted for ACS at 15 hospitals in Northern Italy comparing men and women data. The study period was defined as the time between the first confirmed case of Covid-19 in Italy (February 20, 2020) and March 31, 2020. We compared hospitalization rates between the study period and two control periods: the corresponding period during the previous year (February 20 to March 31, 2019) and the earlier period during the same year (January 1 to February 19, 2020). Incidence rate ratios comparing the study period with each of the control periods were calculated with the use of Poisson regression. Of the 547 patients who were hospitalized for ACS during the study period, only 127 (23%) were females, accounting for a mean of 3.1 admissions per day, while ACS hospitalized males were 420, with a mean of 10.2 admissions per day. There was a significant decrease driven by a similar reduction in ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) diagnosis in both sexes compared to the control periods. A trend toward a greater reduction in admitted females was shown in the intra-year control period (46% admission reduction in females vs 37% in males, with females accounting for 26% of ACS, P=0.10) and a significant reduction when compared to the previous year control period (40% admission reduction in females vs 23% in males, with females accounting for 28% of ACS, P=0.03), mainly related to Unstable Angina diagnosis. The Covid-19 pandemic period closed the gap between men and women in ACS, with similar rates of reduction of hospitalized STEMI and NSTEMI and a trend toward greater reduction in UA admission among women. Furthermore, many typical differences between males and females regarding ischemic heart disease presentations and vessel distribution were leveled.
Sections du résumé
BACKGROUND
BACKGROUND
Mortality from acute coronary syndromes (ACS) is strictly related to early management. As female patients usually experience longer delays before diagnosis and treatment, we assessed whether women were more affected by the dramatic drop in hospital admissions for ACS during the Covid-19 pandemic.
METHODS
METHODS
We performed a retrospective analysis of clinical and angiographic characteristics of consecutive patients who were admitted for ACS at 15 hospitals in Northern Italy comparing men and women data. The study period was defined as the time between the first confirmed case of Covid-19 in Italy (February 20, 2020) and March 31, 2020. We compared hospitalization rates between the study period and two control periods: the corresponding period during the previous year (February 20 to March 31, 2019) and the earlier period during the same year (January 1 to February 19, 2020). Incidence rate ratios comparing the study period with each of the control periods were calculated with the use of Poisson regression.
RESULTS
RESULTS
Of the 547 patients who were hospitalized for ACS during the study period, only 127 (23%) were females, accounting for a mean of 3.1 admissions per day, while ACS hospitalized males were 420, with a mean of 10.2 admissions per day. There was a significant decrease driven by a similar reduction in ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) diagnosis in both sexes compared to the control periods. A trend toward a greater reduction in admitted females was shown in the intra-year control period (46% admission reduction in females vs 37% in males, with females accounting for 26% of ACS, P=0.10) and a significant reduction when compared to the previous year control period (40% admission reduction in females vs 23% in males, with females accounting for 28% of ACS, P=0.03), mainly related to Unstable Angina diagnosis.
CONCLUSION
CONCLUSIONS
The Covid-19 pandemic period closed the gap between men and women in ACS, with similar rates of reduction of hospitalized STEMI and NSTEMI and a trend toward greater reduction in UA admission among women. Furthermore, many typical differences between males and females regarding ischemic heart disease presentations and vessel distribution were leveled.
Types de publication
Journal Article
Langues
eng
Pagination
506-513Informations de copyright
AJCD Copyright © 2020.
Déclaration de conflit d'intérêts
None.
Références
Heart. 2009 Jan;95(1):20-6
pubmed: 18463200
Catheter Cardiovasc Interv. 2018 Jul;92(1):E1-E8
pubmed: 28699188
J Interv Cardiol. 2015 Apr;28(2):132-40
pubmed: 25884896
Eur J Prev Cardiol. 2012 Feb;19(1):95-101
pubmed: 21450613
BMJ Open. 2014 Oct 31;4(10):e005742
pubmed: 25361835
J Am Coll Cardiol. 2015 Oct 27;66(17):1918-33
pubmed: 26493665
Eur Heart J. 2008 Apr;29(7):932-40
pubmed: 18334475
JAMA. 2010 Aug 18;304(7):763-71
pubmed: 20716739
J Am Coll Cardiol. 2020 Jun 9;75(22):2871-2872
pubmed: 32283124
BMJ Open. 2012 Mar 27;2(2):e000726
pubmed: 22457480
Curr Atheroscler Rep. 2015 Aug;17(8):49
pubmed: 26108894
BMJ. 2012 Jan 25;344:e356
pubmed: 22279115
N Engl J Med. 2020 Jul 2;383(1):88-89
pubmed: 32343497
Med J Aust. 2018 Aug 6;209(3):118-123
pubmed: 30025513
J Am Coll Cardiol. 2016 Jan 19;67(2):127-135
pubmed: 26791057
Patient Educ Couns. 2005 Jan;56(1):45-54
pubmed: 15590222
Eur Heart J. 2020 Jun 7;41(22):2083-2088
pubmed: 32412631
Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e004437
pubmed: 29449443